Slingshot members are tracking this corporate initiative:
Vertex (VRTX) and Merck KgaA (MKGAY) Announce Collaboration and License Agreement Covering Four Oncology R&D Programs
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Jan 11, 2017 Projected Implementation: Q1, 2017 Relevance Tracked Until: Q1, 2019
Don’t see a project related to the strategic initiative you care about?
Related Keywords Ataxia Telangiectasia, Rad3-related Protein Inhibitor, Vx-970, Vx-803, Dna-pk, Vx-984